Skip to content

a Low-residue Diet for Bowel Preparation

Effect of a Prepackaged Low-residue Diet on Bowel Preparation for Colonoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03943758
Enrollment
589
Registered
2019-05-09
Start date
2019-05-10
Completion date
2020-12-31
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Polyp, Colorectal Adenoma

Keywords

Bowel preparation, Polyp, adenoma

Brief summary

Previous researches demonstrated that a prepackaged low-residue diet (LRD) could achieve better bowel preparation quality compared with a self-prepared LRD. However, up to now, there has been no widely acceptable standard of LRD for bowel preparation. Moreover, these prepackaged LRD adopted in previous studies mainly consisted of traditional foods without further processing. Recently, a prepackaged LRD for Special Medical Purpose was specifically designed for bowel preparation. This trail was to compare the impact of the prepackaged LRD on bowel preparation for colonoscopy with self-prepared LRD by patients.

Interventions

Subjects in the prepackaged Low-residue diet group were given 6 packs (60g/pack) pre-packaged formula LRD and asked to use the formula according to individual needs prior to colonoscopy.

Subjects in the self-prepared Low-residue diet group were instructed to follow and prepare an Low-residue diet in the day prior to colonoscopy.

Sponsors

Qilu Hospital of Shandong University
CollaboratorOTHER
Jinan Military General Hospital
CollaboratorOTHER
Wuhan TongJi Hospital
CollaboratorOTHER
Zhejiang University
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
West China Hospital
CollaboratorOTHER
Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients whose age is between 18-65. * Patients who have indications for screening, surveillance and diagnostic colonoscopy. * Patients who have signed inform consent form

Exclusion criteria

* subjects who had known or suspected heart failure, stroke or renal failure; * subjects who had a history of colon surgery or inflammatory bowel disease; * subjects who Patients with had digestion or absorption dysfunction or any dietary restriction due to various reasons; * subjects who had a history of hypersensitivity to any ingredients of laxatives or soy products; * subjects who had high risk factors for bowel preparation such as chronic constipation, Body Mass Index (BMI) greater than 30 or BMI less than 18 Kg/m2, diabetes, spinal cord injury, or use of medications affecting bowel motility within a week; * subjects who had participated in another interventional clinical trial in the previous 60 days; * pregnant or lactating women and those planning to become pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Adequate bowel preparation rate30 minsBoston Bowel Preparation Scale (BBPS) was adopted to evaluate the quality of bowel preparation. Each section of the colon (i.e. the right, the transverse, and the rectosigmoid colon) was rated (0, very poor; 1, poor; 2, good; and 3, very good). Adequate bowel of bowel preparation was defined as a total score ≥ 6 and all colon segments BBPS ≥ 2. Inadequate bowel preparation was defined as any colon segment BBPS ≤ 1.
BBPS scores of the entire colon30 minsThe sum of the scores of three bowel segment.

Secondary

MeasureTime frameDescription
adenoma detection rate (ADR)30 minsadenoma detection rate is the number of patients with at least one adenoma, divided by the total number of patients.
preparation completion rate1 daypreparation completion rate is the number of patients ingest more than 80% laxative, divided by the total number of patients.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026